Alterity Therapeutics Azioni (NASDAQ: ATHE)

Ultime notizie per Alterity Therapeutics (NASDAQ:ATHE) Azioni

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics Ltd

ATHENS INTL ARPT S A by ATHENS INTL ARPT SA

ATHENS INTL ARPT SA U/ADR by ATHENS INTL ARPT SA

ATHENA BITCOIN GLOBAL by ATHENA BITCOIN GLOBAL

Athena Bitcoin Global

Athena Gold Corp

ATHENA GOLD CORP by Athena Gold Corporation

ATHENA TECH ACQ CP II A by Athena Technology Acquisition Corp. II

Athena Technology Acquisition Corp II

Athena Technology Acquisition Corp II Units (1 Ord Share Class A & 1/2 War)

Athena Technology Acquisition Corp II Warrants (01/01/9999)

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 7.750% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series E

Athene Holding Ltd

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 4.875% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series D

Athene Holding Ltd. Depositary Shares, each representing a 1/1,000th Interest in a Share of 6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preference Shares, Series C

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share, Series A

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 5.625% Fixed Rate Perpetual Non- Cumulative Preference Share, Series B, par value $1.00 per share

Athene Holding Ltd. 7.250% Fixed-Rate Reset Junior Subordinated Debentures due 2064

Athenex Inc

ATHENS WTR&SWGE PUB EYDAP by Athens Water & Sewage Public Co. Eydap

Athens Water Supply & Sewerage Co

Athersys Inc

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) moved lower on Tuesday following the launch of a timely and tongue-in-cheek offering <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45216984/blue-point-brewing-co-announces-the-return-of-delayed-pilsner" rel="noreferrer noopener">from one of its subsidiaries.</a>
Blue Point Brewing Co., a well-known craft beer brand under Tilray&#8217;s beverage umbrella, has announced the return of its Delayed Pilsner — a brew created with New York commuters in mind.
The lager, originally developed as a nod to the all-too-frequent public transportation delays in the city, is once again hitting shelves across the Metro New York area.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/25/04/45011379/why-cannabis-stocks-jumped-by-double-digits-and-why-analysts-say-dont-drink-the-kool-aid-in-one-gulp" rel="noreferrer noopener">Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say &#8216;Don&#8217;t Drink The Kool-Aid In One Gulp&#8217;</a>
Carrie Shafir, senior brand director at Tilray Beverages, shared the intention behind the product: &#8220;Delayed Pilsner is our way of helping New Yorkers find a moment of peace amidst the chaos. It&#8217;s a beer that&#8217;s not just refreshing but also comforting.&#8221;
The 16-ounce can features a design inspired by the familiar &#8220;delayed&#8221; signage seen on Penn Station&#8217;s departure boards, particularly referencing Long Island destinations.
It&#8217;s a visual cue that blends humor with an all-too-relatable experience for city residents.
Delayed Pilsner is available in 16oz cans at select retailers and major transit centers across New York.
Tilary Beverages recently launched a new whiskey expression <a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">under its acclaimed&nbsp;</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">Breckenridge Distillery</a><a target="_blank" href="https://www.benzinga.com/25/04/44963595/whats-going-on-with-tilray-brands-stock-today" rel="noreferrer noopener">&nbsp;brand.</a>
The distillery unveiled the latest addition to its cask-finished lineup: Breckenridge Cognac Cask Finish Whiskey, which is available in Colorado with broader U.S. distribution anticipated later this year.
Originally released in 2022 as part of the second Collectors Art Series, this limited edition whiskey has returned with an elevated production run.
Price Action: TLRY shares are trading lower by 3.78% to $0.4229 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45229767/pltr-focused-etfs-down-whats-really-behind-palantirs-plunge-the-numbers-dont-tell-the-full-story" target="_blank" rel="noreferrer noopener">PLTR-Focused ETFs Down: What&#8217;s Really Behind Palantir&#8217;s Plunge? The Numbers Don&#8217;t Tell The Full Story</a></li>
</ul>
Photo: Shutterstock

Cannabis

Equities

News

Markets

Movers

General

TLRY

What's Going On With Tilray Brands Stock On Tuesday?

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) reported better-than-expected revenue for the <a href="https://www.benzinga.com/quote/PLTR/earnings">first quarter on Monday</a>.
Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates.
"Our Rule of 40 score increased to 83% in the last quarter, once again breaking the metric. We are in the middle of a tectonic shift in the adoption of our software," said Alex Karp, co-founder and CEO of Palantir.
Palantir expects second-quarter revenue to be in the range of $934 million to $938 million versus estimates of $899.12 million.
The company also raised its full-year guidance. Palantir expects full-year 2025 revenue of $3.89 billion to $3.90 billion, up from prior guidance of $3.74 billion to $3.76 billion. Analysts were anticipating full-year revenue of $3.75 billion, according to Benzinga Pro.
Palantir raised guidance for full-year U.S. commercial revenue, full-year adjusted income from operations and adjusted free cash flow. The company now expects full-year adjusted free cash flow of $1.6 billion to $1.8 billion, up from prior guidance of $1.5 billion to $1.7 billion.
Palantir shares dipped 12% to trade at $108.89 on Tuesday.
These analysts made changes to their price targets on Palantir following earnings announcement.
<ul>
<li>Mizuho analyst Matthew Broome maintained Palantir Technologies with an Underperform rating and raised the price target from $80 to $94.</li>
<li>Cantor Fitzgerald analyst Thomas Blakey maintained the stock with a Neutral and raised the price target from $98 to $110.</li>
<li>UBS analyst Karl Keirstead maintained Palantir with a Neutral and boosted the price target from $105 to $110.</li>
<li>Morgan Stanley analyst Sanjit Singh maintained Palantir with an Equal-Weight rating and raised the price target from $90 to $98.</li>
<li>Goldman Sachs analyst Gabriela Borges maintained the stock with a Neutral and raised the price target from $80 to $90.</li>
</ul>
Considering buying PLTR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06143226/image-58-1024x626.png" alt="" class="wp-image-904157" style="width:646px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06143226/image-58-1024x626.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06143226/image-58-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06143226/image-58-768x469.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06143226/image-58.png 1096w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Analyst Ratings

Trading Ideas

PLTR

Palantir Analysts Boost Their Forecasts After Q1 Results

Fabrinet&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) shares are trading lower on Tuesday after it reported <a href="https://www.benzinga.com/pressreleases/25/05/g45207128/fabrinet-announces-third-quarter-fiscal-year-2025-financial-results" target="_blank" rel="noreferrer noopener">third-quarter FY25 results on Monday</a>.
Revenue was&nbsp;$871.8&nbsp;million, beating the consensus of&nbsp;$856.62 million. Adjusted EPS&nbsp;of&nbsp;$2.52 exceeded<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">&nbsp;the consensus of&nbsp;$2.49</a>.
Fabrinet CEO Seamus Grady said, &#8220;We delivered another strong telecom performance with growth that more than offset an anticipated sequential decline in datacom revenue. Our team continued to execute very well, producing non-GAAP EPS that also exceeded our guidance.&#8221;
&#8221;Looking ahead, we remain optimistic and confident in our ability to deliver strong execution in the fourth quarter and into fiscal 2026.&#8221;
As of March 28, cash and cash equivalents stood at $306.9 million.
Outlook: Fabrinet expects&nbsp;fourth-quarter&nbsp;FY25 revenue of&nbsp;$860&nbsp;million&nbsp;–&nbsp;$900&nbsp;million, surpassing&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">the street view of&nbsp;$888.62 million</a>.
The company also projects fourth-quarter adjusted EPS of&nbsp;$2.50-$2.70&nbsp;vs. the street view of&nbsp;$2.69.
Rosenblatt analyst Mike Genovese raised the price forecast from $230 to $250, <a href="https://www.benzinga.com/quote/FN/analyst-ratings" target="_blank" rel="noreferrer noopener">while retaining a Buy rating</a>.
The analyst says that Fabrinet&#8217;s outlook in the Telecom sector has become increasingly attractive, and expects Telecom revenue to continue its sequential growth trajectory as both Data Center Interconnect (DCI) and traditional Telecommunications markets rebound.
Also, Genovese writes that Fabrinet is poised to benefit from contract wins with major players like Cisco, Infinera, and Ciena. Simultaneously, investors might observe a less robust performance in the Datacom segment. That may not come as a significant surprise, adds the analyst.
The analyst revised EPS estimates to $10.15 (from $10.17) for 2025 and reiterated FY26 estimates at $11.20.
Investors can gain exposure to the stock via&nbsp;Janus Henderson Small/Mid Cap Growth Alpha ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSMD#NASDAQ">JSMD</a>) and Principal U.S. Small-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSC#NASDAQ">PSC</a>).
Price Action: FN shares are down 7.18% at $205.03 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/05/45193332/ackmans-900-million-power-play-pershing-square-takes-massive-stake-in-howard-hughes-with-48-premium" target="_blank" rel="noreferrer noopener">Ackman&#8217;s $900 Million Power Play: Pershing Square Takes Massive Stake In Howard Hughes With 48% Premium</a></li>
</ul>
Image: Shutterstock

Mid Cap

Guidance

JSMD

Fabrinet Wows Wall Street, But Shares Slide On Mixed Outlook

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 400 points on Tuesday.
The Dow traded down 0.97% to 40,818.82 while the NASDAQ fell 0.94% to 17,676.58. The S&amp;P 500 also fell, dropping, 0.80% to 5,605.36.
Check This Out: <a href="https://www.benzinga.com/25/05/45219974/stryker-lockheed-martin-rockwell-automation-and-more-on-cnbcs-final-trades">Stryker, Lockheed Martin, Rockwell Automation And More On CNBC&#8217;s &#8216;Final Trades&#8217;</a>
Leading and Lagging Sectors Utilities shares rose by 0.8% on Tuesday.
In trading on Tuesday, health care stocks dipped by 1.8%.
Top Headline
The US trade deficit increased to $140.5 billion in March versus market estimates of a $137 billion gap. Imports surged 4.4% to an all-time high of $419 billion last month, while exports rose by 0.2%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) shares shot up 117% to $1.38 after the company announced that its Myrtle recovery centers subsidiary has seen over 400 patients since August 2023.</li>
<li>Shares of Diversified Healthcare Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHC#NASDAQ">DHC</a>) got a boost, surging 36% to $2.9550 after the company reported first-quarter financial results and beat its FFO and sales estimates.</li>
<li>EVgo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) shares were also up, gaining 33% to $3.6895 after the company reported better-than-expected first-quarter sales results and issued FY25 sales guidance with its midpoint above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares dropped 65% to $0.3829 after the company announced a registered direct offering with approximately $7 million gross proceeds.</li>
<li>Shares of bioAffinity Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) were down 54% to $0.1766 after the company announced the pricing of $3.25 million offering.</li>
<li>Tactile Systems Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCMD#NASDAQ">TCMD</a>) was down, falling 30% to $9.73 after the company reported worse-than-expected first-quarter sales results and lowered its FY25 sales guidance below estimates.</li>
</ul>
Commodities In commodity news, oil traded up 3.9% to $59.33 while gold traded up 2.4% at $3,401.70.
Silver traded up 2.7% to $33.36 on Tuesday, while copper rose 1.5% to $4.767.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.45%, while Spain's IBEX 35 Index fell 0.01%. Germany's DAX 40 fell 0.84% and France's CAC 40 fell 0.62% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Hong Kong's Hang Seng Index gaining 0.70%, China's Shanghai Composite Index rising 1.13% and India's BSE Sensex falling 0.19%.
Economics
The US trade deficit increased to $140.5 billion in March versus market estimates of a $137 billion gap.
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Eurozone

Commodities

Intraday Update

BIAF

EVGO

FOXO

NCNA

TCMD

Crude Oil Rises Sharply; US Trade Deficit Widens In March

JPMorgan analyst Christopher Horvers lowered estimates for Lowe&#8217;s Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) ahead of the company&#8217;s first-quarter <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">earnings release on May 21</a>.
The analyst says that based on the industry analysis and data insights, he is cutting first-quarter comparable sales estimates to -2.7%, below the Street&#8217;s consensus of -1.7% and the broader buyside expectations (a <a target="_blank" href="https://www.benzinga.com/quote/LOW/analyst-ratings" rel="noreferrer noopener">decline of 2% to 3.5%)</a>.
Horvers writes that Lowe&#8217;s experienced a more significant headwind from unfavorable DIY weather conditions earlier in the quarter and has underperformed Home Depot more recently, even as weather conditions improved.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44936618/weather-hits-lowes-harder-than-home-depot-as-spring-traffic-heats-up-analyst" rel="noreferrer noopener">Weather Hits Lowe&#8217;s Harder Than Home Depot As Spring Traffic Heats Up: Analyst</a>
The analyst notes that Lowe&#8217;s previously guided to a -2% comp for the first quarter and roughly flat comps for the first half, anticipating a ~$400 million shift of spring <a href="https://www.benzinga.com/calendars/guidance">sales into the second quarter</a>.
While Lowe&#8217;s faces easier weather comparisons in the second quarter (lapping &#8220;one of the worst weather backdrops in 30 years&#8221;), the analyst is slightly lowering second quarter comp estimates to +2% (from +3% previously).
This adjustment reflects the first quarter&#8217;s underperformance relative to management&#8217;s expectations, the uncertain weather outlook, and some underlying softness in the business, the analyst adds.
Further, the analyst estimates first quarter EPS at $2.87, compared to the Street&#8217;s $2.91.
Given the expectation that Lowe&#8217;s will miss its first quarter outlook and considering its positioning relative to Home Depot on tariffs, the analyst anticipates Lowe&#8217;s to adjust its full-year guidance towards the lower end of flat comparable sales and around a 12.3% operating margin. 
The analyst expects the company will reiterate confidence in managing tariffs and safeguarding margins in a less favorable scenario.
LOW Price Action: Lowe&#8217;s shares are down 0.94% at $223.07&nbsp;at publication on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/45037102" target="_blank" rel="noreferrer noopener">Walmart, Home Depot, Target Push Chinese Suppliers To Resume Shipments, Agree To Absorb Tariffs: Report</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Previews

Lowe's Lowdown? Analyst Sees Weaker Sales Than Consensus, Cites Weather Woes

Dub, a fast-growing investing platform enabling users to automatically copy the <a href="https://www.benzinga.com/personal-finance/25/04/44804226/can-you-live-off-dividends-investor-pulls-500-month-from-178k-portfolio-i-feel-more-comfortable-this-way-with-these-6-stock-picks">stock</a> trades of financial <a href="https://www.benzinga.com/general/social-media/25/04/44817229/chinese-tiktok-influencers-expose-cheap-nike-lululemon-suppliers-to-bypass-trump-tariffs">influencers</a>, investors, and public figures, has secured $30 million in Series A funding, the company<a href="https://www.dubapp.com/seriesa"> announced</a> last week.
The round was co-led by Notable Capital and Neo, with participation from Sandberg Bernthal Venture Partners, Peak6 Strategic Capital, and Correlation Ventures. Additionally, Dub<a href="https://www.prnewswire.com/news-releases/dub-raises-30m-to-scale-copy-trading-and-transform-retail-investing-302443669.html"> revealed</a> a $5.5 million venture debt facility from Silicon Valley Bank.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">A New Approach to Retail Investing Gains Momentum</h2>
Founded in 2021 by Harvard dropout Steven Wang, Dub is tapping into a generational shift in investment behavior. Instead of focusing on traditional stock picking, the app encourages users to follow people whose investment strategies they trust, according to<a href="https://fortune.com/article/copy-trading-dub-30-million-series-a-notable-capital-neo/"> Fortune</a>.
Rep. Nancy Pelosi (D-CA) has emerged as a popular figure on the platform, with over 13,000 users opting to mirror her trades, Fortune reported. Pelosi's high-performing portfolio, publicized through financial data aggregators like Quiver Quantitative, has drawn widespread interest for years.
According to Fortune, Dub's traction reflects a broader trend among younger investors, who are increasingly influenced by online communities and social media rather than institutional advisors. Wang said this model simplifies investing and lowers the barrier to entry by transforming complex decisions into followable actions.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
Dub's early momentum was fueled by a high-powered seed round led by Tusk Venture Partners and supported by a diverse group of heavyweight backers across finance, tech, and entertainment. According to a<a href="https://www.prnewswire.com/news-releases/first-ever-copy-trading-platform-dub-raises-17m-seed-round-from-a-list-vcs-and-individual-investors-302067967.html"> statement</a> in February 2024, investors include Uber (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) CEO Dara Khosrowshahi, Robinhood (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) co-founder Nathan Rodland, Apex Fintech Solutions CEO Bill Capuzzi, former Federal Reserve vice chair and TIAA CEO Roger Ferguson Jr., and OneRepublic frontman Ryan Tedder.
<h2 class="wp-block-heading">Retail Access Meets Influencer Strategy</h2>
Dub's core feature, a one-tap system to replicate another user's portfolio, offers users a way to invest by following real people they trust. The platform is designed to help users build wealth alongside stock influencers, expert investors, or even peers. In contrast to platforms that promote speculative trading, Dub positions itself as an educational and transparent marketplace focused on long-term strategy.
The company's creator program, operated through Dub Advisors, rewards verified portfolio creators with royalties. This system monetizes financial knowledge by turning curated strategies into investable products. According to Dub's statement last week, this feature creates a new financial class of investor-influencers, who benefit both from the performance of their portfolios and the community engagement they generate.
This model addresses persistent gaps in market participation. According to Dub, nearly 40% of Americans still do not own any stock, while 88% of equity wealth is concentrated in the hands of the wealthiest 10%. Wang says on the app's website that Dub is designed to reverse this imbalance by offering tools that empower first-time and everyday investors to make informed decisions without needing to master market analysis themselves.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">Investors Back a Platform Built for the Next Generation</h2>
The $30 million funding round marks a vote of confidence from high-profile investors who believe Dub is building more than just another investing app. Hans Tung, managing partner at Notable Capital and a Dub board member, said in Dub's statement that the platform addresses the needs of retail consumers while also spotlighting proven investors who might otherwise remain under the radar.
Ali Partovi, CEO at Neo echoed this sentiment, describing Dub's ambitions as "breathtaking" and positioning the company as a catalyst in the emerging creator-investor economy.
Dub has now raised $47 million in total and surpassed one million downloads. With the latest funding, the company plans to expand its feature set, scale its infrastructure, and make regulated, transparent copy-trading available to a wider audience.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

HOOD

UBER

Dub Raises $30M With Backing From Uber CEO Dara Khosrowshahi, Robinhood Co-Founder Nate Rodland To Let Users Copy Nancy Pelosi's Stock Trades

WIIM

Nuveen Arizona Dividend Advantage Municipal Funds 3

OKLO

Shares of nuclear-linked stocks are trading higher. Axios reported the White House is seeking to hasten nuclear deployment.

Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) posted upbeat results for the <a href="https://www.benzinga.com/quote/F/earnings">first quarter on Monday</a>.
Ford Motor reported quarterly earnings of 14 cents per share, which beat the analyst consensus estimate of two cents, but is down from earnings of 49 cents per share from the prior year's quarter. Quarterly revenue came in at $37.42 billion, which beat the analyst consensus estimate of $36.2 billion and is down from revenue of $39.89 billion from the same period last year.
"We are strengthening our underlying business with significantly better quality and our third straight quarter of year-over-year cost improvement, excluding the impact of tariffs,&#8221; said Ford CEO Jim Farley. &#8220;Ford Pro, our largest competitive advantage, is off to a strong start to the year, gaining market share in the most profitable U.S. and European customer segment."
Ford suspended its financial guidance, including full-year adjusted EBIT and adjusted free cash flow, due to tariff-related uncertainty.
Ford Motor shares gained 2.8% to trade at $10.46 on Tuesday.
These analysts made changes to their price targets on Ford Motor following earnings announcement.
<ul>
<li>Piper Sandler analyst Alexander Potter maintained Ford Motor with a Neutral and lowered the price target from $9 to $8.5.</li>
<li>Goldman Sachs analyst Mark Delaney maintained the stock with a Neutral and raised the price target from $9 to $10.</li>
</ul>
Considering buying CL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image is-resized"><img decoding="async" src="blob:https://editorial.benzinga.com/f229759b-586a-4cad-97b8-a35cc80dc023" alt="" style="width:596px;height:auto" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

These Analysts Revise Their Forecasts On Ford Motor Following Q1 Results

TreeHouse Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) shares are <a href="https://www.benzinga.com/movers" target="_blank" rel="noopener">trading lower on Tuesday</a> after the company reported its first-quarter FY25 earnings.
The company reported a <a href="https://www.benzinga.com/pressreleases/25/05/n45216855/treehouse-foods-inc-reports-first-quarter-2025-results">first-quarter FY25 revenue decline </a>of 3% year-on-year to $796 million, beating the analyst consensus estimate of $790.42 million.
The net sales decrease was primarily due to unfavorable volume/mix related to planned margin management actions,&nbsp;broader macroeconomic consumption trends, and&nbsp;service impacts related to the voluntary recall of frozen griddle products.&nbsp;
Also Read: <a href="https://www.benzinga.com/25/05/45224441/food-service-provider-aramark-posts-2-revenue-growth-in-q2">Food Service Provider Aramark Posts 2% Revenue Growth In Q2</a>
Gross margin for the quarter expanded 90 basis points Y/Y to 14.5%. Adjusted EBITDA from continuing operations totaled $57.5 million, and the margin was 1.8%.
The company reported an operating loss of $(5.5) million compared to a loss of $(5.2) million last year. Operating expenses climbed 3% year over year to $120.7 million.
Adjusted EPS of $0.03 <a href="https://www.benzinga.com/earnings">beat the consensus</a> estimate of $(0.19). TreeHouse held $16.4 million in cash and equivalents as of March-end.
Outlook: TreeHouse reaffirmed its FY25 sales outlook of $3.34 billion—$3.40 billion, up from an estimate of $3.36 billion. The company expects FY25 adjusted EBITDA of $345 million—$375 million and capital expenditures of $125 million.
TreeHouse anticipates second-quarter sales of $785 million -$800 million versus an estimated $785.69 million.
Price Action: THS shares&nbsp;traded lower by 5.18% at $22.24 at last check Tuesday.
Read Next: <a href="https://www.benzinga.com/25/05/45207560/expedia-faces-turbulence-as-us-travel-trend-weakens-says-analyst">Expedia Faces Turbulence As US Travel Trend Weakens, Says BofA Analyst</a>
Photo: Shutterstock

Why Food Processing Firm TreeHouse Foods Stocks Are Diving Today

NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) announced today that its Board of Directors has authorized the repurchase of up to an aggregate of $750 million of its outstanding common stock.&nbsp; The repurchase authorization does not have an expiration date. The purchases will occur from time to time in the open market and/or in privately negotiated transactions as market conditions permit.&nbsp; The Company indicated that the authorization is a continuation of the stock repurchase program that began in 1994 and is consistent with NVR's strategy of maximizing shareholder value.&nbsp; Consistent with prior authorizations, this new authorization prohibits the Company from purchasing shares from the Company's officers, directors, Profit Sharing/401(k) Plan Trust or Employee Stock Ownership Plan Trust.&nbsp; As of May 5, 2025, NVR had 2,924,012 total shares of common stock outstanding.

Buybacks

NVR Board Authorizes Repurchase Of Up To Aggregate Of $750M Of Outstanding Common Stock

Zimmer Biomet Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/quote/ZBH">first quarter on Monday</a>.
The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 billion, up 1.1% on a reported basis (+2.3% on constant currency), almost in line with the consensus of $1.9 billion.
&#8220;We are proud of our team&#8217;s continued execution and performance to start the year, as we delivered solid first quarter results and advanced our bold innovation agenda,&#8221; said Ivan Tornos, Zimmer Biomet&#8217;s President and Chief Executive Officer.
The company expects fiscal year 2025 adjusted EPS of $7.90-$8.10, down from prior guidance of $8.15-$8.35 versus consensus of $8.19.
The company expects 2025 revenue growth of 5.7% – 8.2% compared to 1%-3.5% expected earlier. It expects a foreign currency exchange impact of 0.0%-0.5%.
Zimmer Biomet shares gained 0.7% to trade at $91.08 on Tuesday.
These analysts made changes to their price targets on Zimmer Biomet following earnings announcement.
<ul>
<li>Baird analyst Jeff Johnson maintained Zimmer Biomet Holdings with an Outperform rating and lowered the price target from $130 to $115.</li>
<li>Wells Fargo analyst Larry Biegelsen maintained the stock with an Equal-Weight rating and lowered the price target from $113 to $98.</li>
<li>JP Morgan analyst Robbie Marcus maintained the stock with an Overweight rating and lowered the price target from $128 to $105.</li>
<li>Morgan Stanley analyst Cecilia Furlong maintained the stock with an Equal-Weight rating and lowered the price target from $115 to $95.</li>
<li>RBC Capital analyst Shagun Singh maintained Zimmer Biomet with an Outperform and lowered the price target from $125 to $112.</li>
<li>Stifel analyst Rick Wise maintained Zimmer Biomet with a Buy and lowered the price target from $138 to $115.</li>
<li>Raymond James analyst Jayson Bedford maintained Zimmer Biomet with an Outperform rating and lowered the price target from $119 to $104.</li>
<li>Goldman Sachs analyst David Roman maintained the stock with a Neutral and lowered the price target from $120 to $104.</li>
</ul>
Considering buying ZBH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="619" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-1024x619.png" alt="" class="wp-image-904113" style="width:549px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-1024x619.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-768x464.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

KLG stock has given up its prior loss. WK Kellogg shares were trading lower after the company reported worse-than-expected Q1 financial results.

PAAS

RGLD

SBSW

Shares of precious metals stocks are trading higher amid strength in gold and silver.

GlobalFoundries Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>)&nbsp;reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45216979/globalfoundries-reports-first-quarter-2025-financial-results" rel="noreferrer noopener">fiscal first-quarter 2025</a> results on Tuesday. The company&#8217;s quarterly revenue growth of 2% year-on-year to $1.585 billion aligns with the&nbsp;analyst consensus estimate.
The contract chipmaker&#8217;s adjusted EPS of 34 cents beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate</a> of 28 cents.&nbsp;
Smart mobile device revenue declined 14% from a year ago&nbsp;to&nbsp;$586 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43623967/globalfoundries-beats-q4-estimates-margins-shrink-935-million-impairment-charge" rel="noreferrer noopener">GlobalFoundries Explores Merger With Taiwan&#8217;s UMC To Strengthen US Semiconductor Industry</a>
Communications infrastructure &amp; data center revenue grew 45% Y/Y to $174 million. Home and industrial IOT revenue increased 6% Y/Y to $328 million. Automotive revenue rose 16% Y/Y to $309 million. Non-wafer revenue grew 8% Y/Y to $188 million.
Margins: The adjusted gross margin declined by 220 bps to 23.9%. The adjusted operating margin increased by 130 bps to 13.4%. The adjusted EBITDA margin declined by 200 bps Y/Y to 35.2%.&nbsp;
As of March 31, 2025, GlobalFoundries generated $331 million in operating cash flow and held $3.7 billion in cash and equivalents.
CEO Tim Breen attributed the quarterly results to design wins and growth in the Automotive, Communications Infrastructure, Datacenter, and Home and Industrial IoT end markets.
Outlook: GlobalFoundries expects second-quarter revenue of $1.425 billion—$1.925 billion versus the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$1.670 billion estimate</a>. The company expects adjusted EPS of $0.31-$0.41 versus&nbsp;the&nbsp;$0.35 estimate. The optimistic guidance signifies stable demand despite choppy auto production and a soft smartphone market, Reuters reported Tuesday.
The Trump administration&#8217;s global tariff plans threatened the semiconductor industry. Tariffs on automakers, GlobalFoundries&#8217; third-largest end-market, have already kicked in.
Outgoing CEO Thomas Caulfield&nbsp;mentioned tariffs on foreign-made chips&nbsp;could help U.S. manufacturers&nbsp;like GlobalFoundries by redirecting customers toward chips made in U.S. factories.
Policy uncertainty is also clouding the chip industry, which is bracing for potential changes to the Biden administration&#8217;s CHIPS Act.
Price Action:&nbsp;GFS stock is down 3.57% to $34.60 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/upgrades/25/02/43668326/globalfoundries-gains-analyst-upgrade-eyes-growth-in-automotive-and-ai-powered-data-centers" target="_blank" rel="noreferrer noopener">GlobalFoundries Gains Analyst Upgrade, Eyes Growth In Automotive And AI-Powered Data Centers</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Tech

Media

GlobalFoundries Q1 Performance Shows Smartphone Slowdown And Tariff Impact

Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) analysts highlight the company&#8217;s opportunity in AI, government and commercial sectors after<a href="https://www.benzinga.com/news/earnings/25/05/45208000/palantir-q1-earnings-revenue-beat-eps-in-line-customer-count-up-39-company-raises-guidance-citing-surging-and-ferocious-growth"> first-quarter financial results. </a>
<ul>
<li>Bank of America analyst Mariana Perez Mora maintained a Buy rating on Palantir with a $125 price target.</li>
<li>Goldman Sachs analyst Gabriela Borges maintained a Neutral rating and raised the price target from $80 to $90.</li>
<li>Wedbush analyst Dan Ives maintained an Outperform rating and raised the price target from $120 to $140.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/25/05/45221998/palantir-lauds-elon-musks-doge-cuts-calls-it-the-right-thing-for-the-countrygovernment-resembles-a-marbled-wagyu">Palantir Lauds Musk&#8217;s DOGE Cuts, Calls It &#8216;The Right Thing For The Country:&#8217; Government Resembles A &#8216;Marbled Wagyu&#8217;</a>
Bank of America: Palantir&#8217;s first-quarter revenue beat and raised guidance shows accelerated growth, Mora said in a new investor note.
The analyst highlighted that the first-quarter revenue beat came from strong demand for both commercial and government markets.
Mora said the $125 price target is part of a "longer-term valuation methodology" for the stock.
"We think this valuation fairly captures the beneficial position to national security and US government/allies' digital modernization efforts, a leading role in artificial intelligence-powered platforms, opportunistic partnerships, strong balance sheet and strong profitability," Mora said.
Goldman Sachs: Palantir is "still gaining momentum with AI strategy," Borges said in a new investor note.
Borges said the debate on the medium-term ecosystem remains.
"We believe the enterprise ecosystem continues to turn to Palantir as a proven way of executing AI strategy while alternatives are relatively more challenging to adopt," Borges said.
Palantir can also benefit from the defense tech industry, which is on track for "meaningfully more traction,&#8221; Borges adds. "We continue to view Palantir as well positioned to continue to deliver best-in-class growth given the secular trend towards enterprise AI adoption."
Wedbush: Palantir bull Ives raises the price target after the Q1 results. He again refers to the company as the "Messi of AI."
"The company continues to capitalize on the AI demand wave with its AIP product moat gaining further traction moving forward," Ives said.
The analyst said Palantir's multi-million dollar deals in the pipeline show the company's "land and expand strategy" is working.
Ives also highlighted Palantir's traction gains in Europe with a recent NATO partnership.
"We view Palantir as a generation tech name that we see as a trillion market cap over the next three years with PLTR being a core name in the AI Revolution theme over the coming years."
PLTR Price Action: Palantir stock is down 14.1% to $106.30 on Tuesday versus a 52-week trading range of $63.40 to $125.41. Palantir stock is up 41.3% year-to-date in 2025 and up over 320% in the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank">EXCLUSIVE: April&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?</a></li>
</ul>
Image: Shutterstock

Reiteration

Palantir Stock A 'Core Name In AI Revolution': Analysts Expect $1 Trillion Market Cap In 3 Years

Legendary investor Warren Buffett announced he is stepping down as the CEO of Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) at the end of 2025, ending a run of leading the conglomerate that has often <a href="https://www.benzinga.com/general/education/25/01/42832123/warren-buffett-beats-sp-500-in-2024-how-oracle-of-omahas-returns-compare-over-past-20-years">outperformed the S&amp;P 500.</a>
Here's a look at how Buffett got started with Berkshire Hathaway and how much investing alongside him could have been worth.
What Happened: Buffett is one of the greatest investors of the current generation. He is known for his buy-and-hold approach to investing and has used that approach in his life, living in the same house<a href="https://www.benzinga.com/news/24/09/41095962/billionaire-warren-buffett-still-lives-in-an-old-corner-house-he-purchased-for-32k-i-couldnt-imagine" target="_blank" rel="noreferrer noopener"> for the past 65 years.</a>
Before his buy-and-hold approach, which is still used today, Buffett was interested in purchasing low-priced stocks in the 1960s, including well-run companies trading at low prices.
"If (the stocks) were cheap enough, he didn't care it was a lousy company and lousy management. He knew he was going to make money anyways because of the cheapness," Berkshire Vice Chairman&nbsp;Charlie Munger&nbsp;said in the "Becoming Warren Buffett Documentary," CNBC&nbsp;<a href="https://www.cnbc.com/2017/12/12/buffett-bought-berkshire-hathaway-shares-for-7-dollars-and-50-cents-each.html" target="_blank" rel="noreferrer noopener">reported</a>.
Buffett&nbsp;<a href="https://www.berkshirehathaway.com/SpecialLetters/WEB%20past%20present%20future%202014.pdf" target="_blank" rel="noreferrer noopener">bought&nbsp;</a>his first shares of textile company Berkshire Hathaway in December 1962 for $7.50 each.
"I bought the first shares of Berkshire in 1962 and it was a northern textile business destined to become extinct eventually," Buffett said. "It was a statistically cheap stock and a terrible business."
Buffett saw an opportunity at a low price.
"Berkshire Hathaway was closing mills, and as they close mills, it would free up some capital, and then they would re-purchase shares. So I bought some stock with the idea that there would be another tender offer at some point, and we would sell the stock at a modest profit," he said.
Buffett was right, as he <a href="https://www.benzinga.com/general/education/24/08/40652464/warren-buffett-celebrates-94th-birthday-with-1-trillion-market-cap-milestone-a-look-back-at-hig" target="_blank" rel="noopener">received an offer </a>from Berkshire Hathaway to buy his 7% stake in the company. When asked at what price he would sell the holdings, Buffett told Berkshire head Seabury Stanton the price would be $11.50. Stanton agreed but later sent a letter with an offer for $11.375.
The Oracle of Omaha was taken aback by the letter and offer, which led him to refuse to tender his shares.
"That was a monumentally stupid decision," Buffett said of this move.
"That made me very mad, so I just started buying more stock. I just felt that I had been double-crossed by the management."
Buffett began buying more shares and eventually took control of Berkshire Hathaway. Seabury was let go from the company.
The textile business proved okay for Buffett for a couple of years before shutting down in 1985 and becoming what Buffett has called one of his worst investments of all time.
Over the years, Berkshire Hathaway became more than just a textile business, <a href="https://www.benzinga.com/general/entertainment/22/03/26224759/warren-buffett-owns-what-10-berkshire-acquisitions-you-may-have-forgotten" target="_blank" rel="noopener">buying up companies </a>such as Geico, See's Candies, Fruit of the Loom, Dairy Queen, and others.
Buffett also used the company's cash to <a href="https://www.benzinga.com/general/education/25/05/45208955/warren-buffetts-giant-berkshire-portfolio-top-10-includes-banks-oil-and-apple">acquire stakes in publicly traded companies</a> such as Coca-Cola Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and others.
Read Also: <a href="https://www.benzinga.com/25/05/45184410/warren-buffett-to-step-down-as-berkshire-hathaway-ceo-by-end-of-year-asks-board-to-confirm-greg-abel-as-successor">Warren Buffett To Step Down as Berkshire Hathaway CEO by End of Year, Asks Board To Confirm Greg Abel as Successor</a>
Investing $1,000 in Berkshire Hathaway: As Buffett's first investment took place in Berkshire Hathaway in 1962, there's a good chance that if you're reading this, you might not have been born yet or old enough to buy stock.
If you, your parent, or your grandparent were lucky enough to invest in Berkshire Hathaway stock when Buffett did or when he started accumulating more shares, the returns would be incredible.
Investing $1,000 in Berkshire Hathaway in December 1972 for $7.50 a share at the time Buffett bought shares could have purchased 133.33 shares.
The $1,000 investment would be worth $102,421,161.64 today, based on the current price of Berkshire Hathaway shares, which is $768,35.80.
This represents a return of 10,242,016.2%, or more than 10 million percent since Buffett first invested in Berkshire Hathaway.
Berkshire Hathaway is worth more than&nbsp;$1.1 trillion today and one of the 10&nbsp;most valuable public companies in the world.
Buffett's investment style has produced strong annual returns for investors over the years.
While the hypothetical investment could have people wishing they invested back in 1962 with the Oracle of Omaha, the conglomerate owns many businesses and stock holdings that could set the company up for a successful future of annual returns, even without Buffett leading the way as CEO.
You may not be a billionaire like Warren Buffett, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63">check out five stocks flying under the radar that deserve your attention.</a>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Education

Management

AAPL

If You Invested $1,000 In Berkshire Hathaway Stock When Warren Buffett Did, Here's How Much You'd Have Now

<a href="https://asia.nikkei.com/Business/Energy/Mitsubishi-Heavy-talks-to-200-suppliers-to-rebuild-Japan-nuclear-reactors">https://asia.nikkei.com/Business/Energy/Mitsubishi-Heavy-talks-to-200-suppliers-to-rebuild-Japan-nuclear-reactors</a>

'Mitsubishi Heavy talks to 200 suppliers to rebuild Japan nuclear reactors'- Nikkei Asia

Eighty percent of small American businesses that buy from China will "just die," Flexport CEO Ryan Petersen said during an April 24 appearance on &#8220;<a href="https://www.youtube.com/watch?v=-dgHWv-Dh6Q&amp;t=3326s">The Prof G Pod</a>,&#8221; a podcast hosted by Scott Galloway.
Petersen warned that the U.S.&#8217;s 145% tariff on Chinese imports could lead to &#8220;mass bankruptcies&#8221; and widespread job losses across the country.
Petersen, who founded Flexport in 2013 and raised $935 million in 2022 at an $8 billion valuation, explained that most products affected are not essentials. &#8220;We have customers that buy pizza ovens in China, like for your backyard,&#8221; he said.&nbsp;
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
&#8220;They&#8217;re&nbsp; really cool products. When the price goes up 50% or more, you might go out and buy pizza from Domino&#8217;s or something.&#8221; Petersen suggested the government could ultimately &#8220;back down&#8221; from the trade war as the pressure mounts.
<h2 class="wp-block-heading">Tariff Chaos Hits Small Importers First</h2>
Flexport has already seen a sharp 35% decline in ocean freight bookings from China within a week of the tariff rollout, Peterson<a href="https://x.com/typesfast/status/1912890264135577990"> posted on X</a> on April 17. This early signal reflects growing uncertainty among small importers, many of whom lack the financial buffer to absorb sudden cost hikes.
Business owners across industries are struggling. Chelsey Brown, owner of the home décor company Curio Blvd told the<a href="https://www.ft.com/content/ae8277b7-f8fb-4262-811d-ed8f3d9c70fe"> Financial Times</a> she had to stop operations entirely. Jacob Sendowski, co-founder of Souper Cubes, estimated it would cost millions to relocate production away from China.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">De Minimis Change Fuels Tension</h2>
Adding to the pressure, the U.S. eliminated the de minimis exemption on May 2, requiring tariffs on low-value parcels previously exempt. The move will affect over 4 million small shipments from China daily, according to the<a href="https://apnews.com/article/1b52319a85572331baf31cb6287ecddf"> Associated Press</a>, intensifying costs for sellers relying on direct-to-consumer shipping models.
The tariff escalation is already triggering legal pushback. Five small businesses from various states have filed suit in the U.S. Court of International Trade, arguing that the administration&#8217;s use of the International Emergency Economic Powers Act violates the Constitution&#8217;s separation of powers.
<h2 class="wp-block-heading">Economy Shows Signs of Strain</h2>
U.S. gross domestic product shrank <a href="https://www.bea.gov/sites/default/files/2025-04/gdp1q25-adv.pdf">0.3% in Q1 2025</a>—the first contraction in three years—due to falling imports and reduced government spending. This economic downturn is being closely watched as inflation and trade disruptions continue to ripple.
"I may not want to go higher, or I may not want to even go up to that level&#8230; because you want people to buy," President Donald Trump <a href="https://www.youtube.com/watch?v=qXgnqYC83pQ">told reporters</a> on April 17, signaling he might not escalate tariffs further.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">Airlines, Farmers Brace for Fallout</h2>
The pain isn&#8217;t limited to retail. The <a href="https://nypost.com/2025/04/28/business/us-agriculture-industry-in-full-blown-crisis-as-trump-tariffs-shrink-chinese-orders">New York Post</a> reported last week that U.S. farmers are facing a &#8220;full-blown crisis&#8221; after China canceled 12,000 tons of pork orders and slashed soybean purchases by 97% in one week.
In the aviation sector, Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) CEO Bob Jordan told<a href="https://www.bloomberg.com/news/articles/2025-04-24/southwest-ceo-says-us-airline-industry-is-already-in-a-recession"> Bloomberg</a> in an interview late last month that the airline industry is already in a recession. &#8220;When consumers are uncertain, they pull back. Consumers can immediately stop spending,&#8221; he said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Flexport CEO Ryan Petersen Warns Of 'Mass Bankruptcies' As 80% Of Small Businesses Could 'Just Die' Under 145% China Tariffs

<a href="https://www.axios.com/pro/energy-policy/2025/05/06/scoop-white-house-seeks-to-hasten-nuclear-deployment">https://www.axios.com/pro/energy-policy/2025/05/06/scoop-white-house-seeks-to-hasten-nuclear-deployment</a>

'White House seeks to hasten nuclear deployment'- Axios

Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) shares continue to slide lower on Tuesday. This comes after yesterday's decline of more than 7%. Earnings came in at 92 cents, which was slightly ahead of estimates. But the $13.07 billion of revenue was lower than the $13.14 billion analysts were looking for.
Despite today's move, there is a good chance that it could reverse and head higher. This is why we have made it our Stock of the Day.
Sometimes, technical market dynamics can be more important than the fundamental news that has been reported. For example, as you can see on the chart, despite yesterday's news and panic sellers, the stock found a bottom right around $54.25.
It wasn't a coincidence there was support around this level. Levels that had previously been bottoms can become so again if a stock drops back to them.
This happens because of people who sold their shares when it was at support. A number of them regretted their decision to sell when the price rallied afterward. Some of them decided that if and when it was eventually possible, they would buy their shares back if they could do so at their selling price.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-1024x560.png" alt="" class="wp-image-904072" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one.png 1489w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/government/regulations/25/05/45227387/bessent-signals-imminent-trade-deals-dismisses-recession-fears-as-stocks-rebound">Bessent Signals Imminent Trade Deals, Dismisses Recession Fears As Stocks Rebound</a>
So when Tyson fell back to around $54.25 in January 2025, remorseful sellers from July 2024 came into the market as buyers. The large number of these orders they placed caused support at the same price.
A similar thing just occurred. On Monday, the low trade was right around this price, and the last two times the stock found this support, a rally followed.
Stocks tend to rally after they drop to support. This occurs when the traders and investors who created the support with their buy orders become aggressive.
They are concerned that others who wish to purchase shares will be willing to pay higher prices than they are. They know that if this happens, the sellers will go to them.
These concerned buyers don't want to miss their trades, so they increase the prices they are willing to pay. Other concerned buyers see this and do the same.
This can result in a bidding war that could force the price higher. It happened the past two times with Tyson at this support. It may be about to happen again.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45224883/oil-soars-above-59-as-middle-east-airstrikes-jolt-markets">Oil Soars Above $59 As Middle East Airstrikes Jolt Markets</a>
Photo: Piotr Swat via Shutterstock

Technicals

Stock Of The Day: Will The Tyson Food Rally Continue?

Press Releases

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Health Care

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

Peraso Inc. (NASDAQ: PRSO): The Only Pure-Play mmWave Stock Poised for Growth – More Stocks Inside

Alterity Therapeutics Raises A$40.0 million in Placement

Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy

Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Comments

Alterity Therapeutics

Notizie

Ultime notizie per Alterity Therapeutics (NASDAQ:ATHE) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO